Those Flashing Glasses in the Clinic: What They Are, How They Work, and Why We Use Them
If you have sat in our clinic and spotted a pair of glasses with little LED lights blinking inside the lenses, you have probably wondered what on earth they are. Fair enough. They look a bit strange.
These are called Eyelights. They are a neurostimulation tool that uses patterned light delivered directly to the eye to influence brain activity. And before you scroll away thinking this sounds like something from a sci-fi film, stay with me, because the neuroscience underneath them is genuinely interesting, and I think you deserve to understand it properly rather than just take my word for it.
That is actually the whole point of this post. I want to explain how Eyelights work, what the science does and does not yet tell us, and how they fit into the broader way we approach brain-based care at The Togetherness Project.
The Eye Is Not Just for Seeing
Most of us think of the eye as a camera. Light comes in, an image forms, we see things. But the eye is far more than that. It is a direct extension of the central nervous system, and the signals it sends into the brain travel along multiple pathways, many of which have nothing to do with conscious vision at all.
One of those pathways is called the retinohypothalamic tract. That is a mouthful, so here is what it actually means: retino refers to the retina at the back of your eye, and hypothalamic refers to the hypothalamus, a small but enormously powerful region deep in the brain that regulates your sleep cycles, stress hormones, body temperature, and much of your endocrine system. This pathway is the reason that light has such a profound effect on your mood, your sleep, and your energy. It is the same pathway that is activated during clinical light therapy for depression and seasonal mood changes, which has a solid research base built over several decades.
So when light enters the eye, it is not just hitting the visual cortex at the back of the brain. It is also talking to the hypothalamus, the pineal gland (which produces melatonin), the pituitary gland, and the limbic system, which is involved in emotion and memory. The eye is a surprisingly direct route into the brain's regulatory systems.
The eye is one of the most direct access points we have to the brain. That is not a marketing claim. It is anatomy.
Two Pathways Worth Knowing About
Within the visual system itself, there are two parallel processing streams that handle very different aspects of what we see. They are named the magnocellular pathway and the parvocellular pathway, after the layers of the thalamus where they relay signals. I know those words sound complex, so here is what they actually do.
The magnocellular pathway (magno, from the Latin for large) is the fast lane. It handles motion, spatial position, peripheral vision, and low-contrast information. Think of it as the system that notices things moving in your peripheral vision before you have consciously registered what you are looking at. It connects strongly to the parietal lobes, which are involved in spatial awareness, coordination, and attention. Research has found that atypical magnocellular processing shows up in some people with dyslexia and attention difficulties, though this is still an active area of investigation rather than settled science.
The parvocellular pathway (parvo, from the Latin for small) is the detail lane. It handles fine visual information, colour, and object recognition. It connects primarily to the temporal lobes, which are involved in language processing, memory, and recognising emotionally significant information.
Both of these pathways relay through the thalamus, which is often described as the brain's relay station. I prefer to think of it as an active hub rather than a passive post box, because the thalamus does real processing work, and stimulating it has flow-on effects throughout the cortex.
So What Do Eyelights Actually Do?
Now that you have a feel for the pathways involved, the logic of Eyelights becomes clearer.
The device sits in a glasses frame with small LED lights mounted behind the lens. It is programmed to flash on one eye, typically the non-dominant eye. Because the visual system crosses over at a structure called the optic chiasm, stimulating the right eye has a stronger influence on the left hemisphere, and stimulating the left eye has a stronger influence on the right hemisphere. The aim is to target the side of the brain that is less active or less regulated, based on what the assessment has shown.
The upper row of lights flashing more brightly is thought to preferentially engage the parvocellular pathway and temporal lobe circuits. The lower row is thought to preferentially engage the magnocellular pathway and parietal circuits. Colour lenses can also be added, with different colours proposed to interact with these pathways in specific ways.
The theoretical mechanism is called thalamocortical excitation. In plain terms: patterned light stimulates the thalamus via the optic nerve, and the thalamus then activates cortical areas more broadly, increasing arousal and activity in specific brain networks. This is not a fringe idea. Thalamocortical dynamics are central to how neuroscientists currently understand attention, consciousness, and sensory processing.
The neuroscience here is real and well described in the literature. What is less established is whether this specific device, used in these specific ways, produces consistent and clinically meaningful outcomes across different presentations. That distinction matters, and I will come back to it.
What I Can Honestly Tell You About the Evidence
I want to be straight with you here, because I think a lot of practitioners in this space are not.
There is strong, replicated evidence for the broader mechanisms that Eyelights draws on:
Light therapy via the retinohypothalamic pathway has meta-analytic support for circadian disruption and seasonal mood changes.
Photobiomodulation, which uses specific light wavelengths to stimulate brain tissue, has a growing body of randomised controlled trial evidence for traumatic brain injury and mood regulation.
Visual processing interventions targeting magnocellular function have a mixed but active research literature in developmental conditions.
For the Eyelights device itself? The evidence base is currently limited to clinical observation, case reports, and theoretical extrapolation from the above. There are no large-scale randomised controlled trials specific to this device. Practitioners who use it, including me, are working within a theoretical framework that is scientifically credible but not yet fully validated at the clinical trial level.
This is not unusual in neurotherapy. Many of the tools used in this field, including several with much stronger reputations, were adopted ahead of the formal trial evidence and validated over time. That does not make adoption automatically appropriate. It means the bar for transparency, careful monitoring, and honest client communication needs to be higher, not lower.
How We Use Eyelights in Our Practice
Eyelights is never a standalone treatment in our clinic. It forms part of an integrated protocol that is built around what your QEEG and ERP assessment has shown us about your brain.
We consider it when the assessment suggests:
Hemispheric asymmetry, meaning one side of the brain is consistently underactivating relative to the other
Thalamic dysregulation, which can show up in specific EEG patterns linked to attention, sensory processing, or sleep
Clinical presentation that is consistent with magnocellular or parvocellular pathway differences
We do not use it if there is any history of photosensitive epilepsy or active seizure activity. We start conservatively, monitor your response, and adjust based on what we observe. We also integrate it with other approaches, including neurofeedback, neuromodulation, and the relational and somatic work that is central to everything we do.
And we talk to you about it. If you are a client and Eyelights has been suggested as part of your protocol, you should feel completely comfortable asking me why, what we expect to see, and what we will do if it does not seem to be making a difference. That conversation is not an optional extra. It is part of how I practice.
Informed consent is not a form you sign. It is an ongoing conversation, and you are always allowed to ask questions mid-sentence.
Why I Think Transparency Matters Here
I am genuinely curious about tools like Eyelights. The theoretical framework is compelling, the neuroscience is interesting, and in clinical practice I have observed changes in clients that are hard to attribute to other factors. I find that worth exploring.
But I also think the neurotherapy space, like many complementary and integrative health fields, has a habit of running ahead of the evidence and omitting to inform clients about that gap. That does not serve clients well. It does not serve the field well either.
My view is that you can hold genuine clinical curiosity and rigorous honesty at the same time. You can use a tool that has a credible theoretical basis and emerging evidence while being clear about what is established and what is not. That is what I am trying to do here, and it is what I try to do in every session.
If you have more questions about Eyelights, or anything else we use at The Togetherness Project, please just ask. I would genuinely rather you leave knowing where we stand than feeling uncertain and not saying so.
About The Togetherness Project
We are a neurotherapy practice with locations in Hawthorn (Melbourne) and Fremantle (Perth). We offer QEEG and ERP assessment alongside integrative neuromodulation programmes, within a family-informed, trauma-aware approach to brain-based care.